AMENDED and RESTATED LICENSE, DEVELOPMENT & COMMERCIALIZATION AGREEMENT Between SCYNEXIS, Inc. And ELANCO ANIMAL HEALTH, a division of ELI LILLY AND COMPANYLicense, Development & Commercialization Agreement • March 19th, 2014 • Scynexis Inc • Pharmaceutical preparations
This AMENDED and RESTATED LICENSE, DEVELOPMENT & COMMERCIALIZATION AGREEMENT (this “Agreement”) is made and effective as of the last date of signature hereto (the “New Effective Date”) by and between:
